PhD and MSc Theses
PhD and MSc Theses, since 1988
| Student’s Name |
Graduation Year |
Degree |
Abstracts |
Research Name |
| Levin May |
2021 |
PhD |
Abstracts |
Mechanisms of Chemoresistance in Relapsed AML: Towards Efficacious Precision Medicine |
| Golan Maor Yarden |
2019 |
PhD |
Abstracts |
The Role of ZnT2 in Zinc Homeostasis under Pathological and Physiological Conditions |
| Zhitomirsky Binyamin |
2018 |
PhD |
Abstracts |
The Role of Lysosomes in Cancer Multidrug Resistance |
| Drucker-Gonen Nitzan |
2012 |
PhD |
Abstracts |
The Key Role of the Proton-Coupled Folate Transporter (PCFT/SLC46A1) in Folate Homeostasis and Antifolate Resistance |
| Raz Shachar |
2015 |
PhD |
Abstracts |
Molecular Mechanisms Regulating the Expression and Subcellular Localization of Folylpoly-Gamma- Glutamate Synthetase (FPGS) in Folate Metabolism and Antifolate… |
| Bram Airon (Eran) |
2010 |
PhD |
Abstracts |
Cellular and Molecular Mechanisms Underlying ABCG2-Dependent Multi-Drug Resistance in Cancer |
| Ifergan Ilan |
2007 |
PhD |
Abstracts |
The Role of Transporters in Folate Homeostasis and Anticancer Drug Resistance |
| Lasri-Reish Inbal |
2013 |
PhD |
Abstracts |
Human Diseases Based on Mutations in the Membrane Transporters PCFT (SLC46A1) and ZnT-2 (SLC30A2): The Molecular Basis Underlying the Inherited… |
| Goler-Baron Vicky |
2012 |
PhD |
Abstracts |
ABCG2-Rich Extracellular Vesicles: a Determinant of MDR and Targeted Photodynamic Therapy of Cancer |
| Stark Michal |
2007 |
PhD |
Abstracts |
Transcriptional Silencing of the Reduced Folate Carrier as a Novel Mechanism of Antifolate Resistance |
| Rothem Lilah |
2003 |
PhD |
Abstracts |
Characterization of the Moleculr Mechanisms of Resistance to Novel Antifolate Anticancer Drugs |
| Derori Stavit |
1999 |
PhD |
|
Characterization of the Structure-Function Relationship of the Reduced Folate/methotrexate Carrier (RFC) in Malignant Cells |
| Labay Valentina |
1998 |
PhD |
|
Multiclonal Characterization of Drug-Resistance Mechanisms to Antimitotic Anticancer Drugs of the Taxol Family |
| Borgnia Mario |
1996 |
PhD |
|
Molecular Interaction of P-Glycoprotein with Peptide Ionophores: Mechanistic Implications |
| Edelman Ravit |
2016 |
PhD |
|
Hyaluronic Acid-Based Quadrugnostic Nanoparticles for Cancer Therapy |
| Engelberg Shira |
2022 |
PhD |
Abstracts |
Selectively Targeted Drug Delivery System for Efficacious Non-Small-Cell Lung Cancer Treatment |
| Sharma Vinay Kumar |
2023 |
PhD |
Abstracts |
Stimuli Responsive Chromophores |
| Baron Shahaf Dana |
2004 |
PhD |
Abstracts |
Identification and Characterization of the Gene Involved in Rogers’ Syndrome |
| Bar-Zeev Maya |
2018 |
PhD |
Abstracts |
Casein Based Nano-vehicles for Oral Delivery of Chemotherapeutic Combinations to Overcome Multidrug Resistance in Gastric Cancer |
| Shapira Alina |
2012 |
PhD |
|
Beta-Casein Micelles as Nano-Vehicles for Oral Delivery of Hydrophobic Chemotherapeutic Drugs |
| Yunaev Yehoshua Anna |
2019 |
MSc |
Abstracts |
Lysosomotropic Drugs Activate TFEB Via Lysosomal Membrane Fluidization and Consequent Inhibition of mTORC1 Activity |
| Lehvy Adrian Israel |
2019 |
MSc |
Abstracts |
Zinc Transporter Mutations and Expression in Cancer and Transient Neonatal Zinc Deficiency |
| Sheban Daoud |
2016 |
MSc |
Abstracts |
Molecular Basis of Antifolate Resistance in Carcinoma Cells under Hypoxia |
| Turgeman Yamit |
2011 |
MSc |
Abstracts |
Overcoming Multidrug Resistance via Imidazoacridinone- Dependent Lysosomal Photodestruction |
| Shafran Assaf |
2005 |
MSc |
Abstracts |
Single Amino Acid Substitutions in the Multidrug Efflux Transporter ABCG2 Confer High Level Resistance to Various Antifolates |
| Zahavi Efrat |
2005 |
MSc |
Abstracts |
Isolation and characterization of T-cell Receptor-like Antibodies Targeting CDl Molecules |
| Ifergan Ilan |
2003 |
MSc |
Abstracts |
The Role of the Methotrexate Transporter in the Chemotherapy of the Osteosarcoma |
| Kaufman Yotam |
2002 |
MSc |
Abstracts |
Molecular Mechanisms of Antifolate Resistance: Genetic Alterations and Silencing of the hRFC Gene |
| Barr Haim |
1997 |
MSc |
|
Charachterization of Organellar Sites of Cytotoxicity of the Anti-Parasitic Drug Pyrimethamine, and a Mechanism Of Resistance to Anti-Cancer Drugs |
| Derori Stavit |
1995 |
MSc |
|
Interacion of Modulators with the Multidrug Resistance ((Mdr) Phenotype |
| Slotky Jaacob |
1994 |
MSc |
|
Chracterization of a Lipophilic Antifolate Resistance |
| Labay Valentina |
1993 |
MSc |
|
Monitoring Anticancer Drug-Resistan Levels |
| Cohen Lital |
2021 |
MSc |
Abstracts |
Development of Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment |
| Pinhassi Roy |
2008 |
MSc |
Abstracts |
Nano-Sized Polymer-Drug Conjugates for Targeted Delivery and Target-Activated Release of Anti-Cancer Drugs |
| Muallem Merav |
2011 |
MSc |
Abstracts |
Development and Characterization of Nanocrystals for Biological Applications |
